Stem cell biology company Fate Therapeutics files for $69 million IPO – GeekWire
Stem cell biology company Fate Therapeutics files for $69 million IPOGeekWire“Due to their natural ability to self-renew, and to regenerate and repair diseased or damaged tissue, adult stem cells hold considerable therapeutic promise,” the company writes in its SEC filing. “Based on our deep understanding of key biological …Fate Therapeutics, founded by stem cell experts, … Continue reading
